Breaking News Instant updates and real-time market news.

PSDV

pSivida

$2.94

-0.07 (-2.33%)

07:09
10/04/16
10/04
07:09
10/04/16
07:09

pSivida Phase 3 trial of Medidur meets enrollment target

pSivida announced that its second Phase 3 trial of Medidur in chronic, non-infectious posterior segment uveitis met its target enrollment of 150 patients. The trial is being conducted in clinical sites in India, with the same study design and endpoints as the first Phase 3 trial conducted in the U.S., EU and India. The results of both Phase 3 trials will support U.S. product registration, with NDA submission planned for the second half of 2017. Filing for EU registration remains on track for Q1 of 2017. This first Medidur trial met the primary efficacy endpoint of prevention of recurrence of posterior segment uveitis at six months in December 2015. Primary efficacy endpoint readout in the second study is expected in the second half of 2017.

PSDV pSivida
$2.94

-0.07 (-2.33%)

12/17/15
NORL
12/17/15
NO CHANGE
Target $10
NORL
Outperform
Alimera sale would have implications for pSivida, says Northland
Northland analyst Suraj Kalia noted the Reuters report that Alimera Sciences (ALIM), a licensee of pSivida (PSDV), is exploring strategic alternatives. If Alimera get bought, the acquirer could keep its current contractual arrangement with pSivida, under which it is entitled to 20% of "net profits" on sales of Iluvien in DME, in place, or could try to negotiate an upfront lump sum payment to pSivida for Iluvien, the analyst stated. Kalia keeps an Outperform rating and $10 price target on pSivida shares.
12/22/15
NORL
12/22/15
NO CHANGE
Target $10
NORL
Outperform
pSivida' Meddidur results a big positive, says Northland
Northland analyst Suraj Kalia said pSivida announced strong Phase III results from its Medidur uveitis study. Overall, the data improves pSivida's bargaining position if a strategic buyer steps in for partner Alimera, and it positions pSivida strongly from a go-direct strategy perspective, the analyst reported. Kalia rates pSivida an Outperform with a $10 price target on shares.
12/23/15
LTCO
12/23/15
NO CHANGE
Target $12.5
LTCO
Buy
pSivida price target raised to $12.50 from $8 at Ladenburg
Ladenburg analyst Matthew Kaplan raised pSivida's price target to $12.50 from $8 and reiterated his Buy rating following the "outstanding" top-line data for first Medidur Phase 3 trial in treating chronic noninfectious posterior uveitis. Kaplan said the data presents a strong case that the FDA may allow Medidur NDA filing without completion of the 2nd Phase 3 study.
06/23/16
FBRC
06/23/16
NO CHANGE
FBRC
Outperform
pSivida could see positive catalysts shortly, says FBR Capital
FBR Capital analyst Vernon Bernardino thinks pSivida is on track to announce the 12-month data from the first Medidur Phase III trial, which he expects to be a significant catalyst, in July and that an IND filing for a Durasert osteoarthritis product by the company's partner is on track to be announced in the next few weeks. Given the company's upcoming catalysts, its potential to turn positive on cash flow in the near-term and its attractive potential as an acquisition target, the firm reiterates its Outperform rating on pSivida.

TODAY'S FREE FLY STORIES

02:25
02/23/17
02/23
02:25
02/23/17
02:25
General news
FX Update: The dollar has consolidated post-FOMC minutes losses »

FX Update: The dollar has…

OCLR

Oclaro

$9.72

-1.25 (-11.39%)

20:45
02/22/17
02/22
20:45
02/22/17
20:45
Conference/Events
Oclaro management to meet with Jefferies »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

GMS

GMS Inc.

$29.79

-0.52 (-1.72%)

20:32
02/22/17
02/22
20:32
02/22/17
20:32
Syndicate
GMS Inc. 6.95M share Secondary priced at $29.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

APA

Apache

$54.91

-0.98 (-1.75%)

, HRL

Hormel Foods

$37.30

-0.3 (-0.80%)

20:25
02/22/17
02/22
20:25
02/22/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

APA

Apache

$54.91

-0.98 (-1.75%)

HRL

Hormel Foods

$37.30

-0.3 (-0.80%)

KSS

Kohl's

PF

Pinnacle Foods

$54.63

-0.61 (-1.10%)

CHK

Chesapeake

$5.92

-0.16 (-2.63%)

CNK

Cinemark

$43.39

0.51 (1.19%)

AMCX

AMC Networks

$57.50

-0.19 (-0.33%)

W

Wayfair

$41.26

1 (2.48%)

SFM

Sprouts Farmers Markets

$19.00

-0.32 (-1.66%)

TREE

LendingTree

$112.15

-1.45 (-1.28%)

TXMD

TherapeuticsMD

$5.67

0.08 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 16

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 07

    May

  • 11

    May

FIT

Fitbit

$5.88

-0.16 (-2.65%)

20:14
02/22/17
02/22
20:14
02/22/17
20:14
Hot Stocks
Fitbit CEO says early adopter segment saturated, says exploring new form factors »

Speaking during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

SQ

Square

$15.04

0.41 (2.80%)

19:57
02/22/17
02/22
19:57
02/22/17
19:57
Upgrade
Square rating change  »

Square upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

FIT

Fitbit

$5.88

-0.16 (-2.65%)

19:50
02/22/17
02/22
19:50
02/22/17
19:50
Hot Stocks
Fitbit says paid $23M for Pebble assets »

Fitbit disclosed in its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

SBUX

Starbucks

$57.57

0.03 (0.05%)

19:34
02/22/17
02/22
19:34
02/22/17
19:34
Hot Stocks
Market researcher: Starbucks consumer perception dips after refugee hiring news »

Market researcher YouGov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

LB

Labarge

$58.13

0.43 (0.75%)

19:33
02/22/17
02/22
19:33
02/22/17
19:33
Hot Stocks
L Brands sees Q1 comps down high-single to low-double digits »

Sees Q1 Go-Forwards comps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LB

Labarge

$58.13

0.43 (0.75%)

19:32
02/22/17
02/22
19:32
02/22/17
19:32
Hot Stocks
L Brands sees FY17 comps down low-single digits »

Sees FY17 Go-Forward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

F

Ford

$12.67

-0.02 (-0.16%)

19:30
02/22/17
02/22
19:30
02/22/17
19:30
Conference/Events
Ford to host sales conference call »

Ford U.S. Sales Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

GTLS

Chart Industries

$38.51

-1.21 (-3.05%)

19:27
02/22/17
02/22
19:27
02/22/17
19:27
Hot Stocks
Chart Industries CEO Samuel Thomas named executive chairman »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$273.51

-3.88 (-1.40%)

19:24
02/22/17
02/22
19:24
02/22/17
19:24
Periodicals
SolarCity leased with risky homeowners, has ties to foreclosure cases, NYT says »

In "dozens of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

PRU

Prudential

$110.50

-0.72 (-0.65%)

, WFC

Wells Fargo

$58.36

0.11 (0.19%)

19:16
02/22/17
02/22
19:16
02/22/17
19:16
Hot Stocks
Prudential says could seek compensation from Wells Fargo over MyTerm products »

Prudential (PRU) stated…

PRU

Prudential

$110.50

-0.72 (-0.65%)

WFC

Wells Fargo

$58.36

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 13

    Apr

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

PSA

Public Storage

$226.24

-1.49 (-0.65%)

19:15
02/22/17
02/22
19:15
02/22/17
19:15
Earnings
Public Storage reports Q4 core FFO $2.65, consensus $1.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CS

Credit Suisse

$15.35

-0.13 (-0.84%)

19:10
02/22/17
02/22
19:10
02/22/17
19:10
Periodicals
Credit Suisse probed for potentially aiding tax evasion, WSJ says »

Less than three years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

LZB

La-Z-Boy

$28.40

-1.05 (-3.57%)

19:09
02/22/17
02/22
19:09
02/22/17
19:09
Downgrade
La-Z-Boy rating change  »

La-Z-Boy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLD

Cloud Peak

$5.68

-0.19 (-3.24%)

19:06
02/22/17
02/22
19:06
02/22/17
19:06
Syndicate
Cloud Peak 13.5M share Spot Secondary priced at $5.10 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SNAP

Snap Inc

18:47
02/22/17
02/22
18:47
02/22/17
18:47
Periodicals
Snap Inc nears $200M ad deal, NY Post says »

Snap Inc is close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

SBLK

Star Bulk Carriers

$9.59

0.29 (3.12%)

18:40
02/22/17
02/22
18:40
02/22/17
18:40
Earnings
Star Bulk Carriers reports Q4 EPS (29c), consensus (28c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

C

Citi

$60.62

0.07 (0.12%)

18:35
02/22/17
02/22
18:35
02/22/17
18:35
Periodicals
Citi forms regulatory affairs team in D.C., Bloomberg says »

Citi is forming a global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:34
02/22/17
02/22
18:34
02/22/17
18:34
Earnings
PRA Health sees FY17 EPS $3.08-$3.18, consensus $2.96 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

, ATH

Athene Holding

$51.45

0.38 (0.74%)

18:32
02/22/17
02/22
18:32
02/22/17
18:32
Periodicals
Fidelity & Guaranty Life revives sale process, Insurance Insider says »

Fidelity & Guaranty…

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

ATH

Athene Holding

$51.45

0.38 (0.74%)

APO

Apollo Global

$22.25

0.05 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:31
02/22/17
02/22
18:31
02/22/17
18:31
Earnings
PRA Health sees Q1 EPS 57c-62c, consensus 67c »

Sees Q1 service revenues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

NBR

Nabors Industries

$15.44

0.01 (0.06%)

18:30
02/22/17
02/22
18:30
02/22/17
18:30
Earnings
Nabors Industries reports Q4 EPS ($1.17) with items »

Q4 EPS includes 87c in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.